Ceramide kinase (Cerk) emerges as a common therapeutic target for triple positive and triple negative breast cancer cells
Simple Summary Existing chemotherapy treatments for breast cancer patients are high on
toxicity. There are very limited options available for triple-positive breast cancer (TPBC) …
toxicity. There are very limited options available for triple-positive breast cancer (TPBC) …
Unique sphingolipid signature identifies luminal and triple‐negative breast cancer subtypes
Breast cancer (luminal and triple‐negative breast cancer [TNBC]) is the most common
cancer among women in India and worldwide. Altered sphingolipid levels have emerged as …
cancer among women in India and worldwide. Altered sphingolipid levels have emerged as …
RICTOR Drives ZFX-mediated Ganglioside Biosynthesis to Promote Breast Cancer Progression
Sphingolipid and ganglioside metabolic pathways are crucial components of cell signalling,
having established roles in tumor cell proliferation, invasion, and migration. However …
having established roles in tumor cell proliferation, invasion, and migration. However …
[PDF][PDF] mTORC2 Drives ZFX-mediated Ganglioside Biosynthesis to Promote Breast Cancer Progression.
Sphingolipid and ganglioside metabolic pathways are crucial components of cell signalling,
having established roles in tumor cell proliferation, invasion, and migration. However …
having established roles in tumor cell proliferation, invasion, and migration. However …